Investigation of different drug deposition techniques on drug releasing properties of cardiovascular drug coated balloons

Industrial and Engineering Chemistry Research

Volumn 51, Issue 33, 2012, Pages 10800-10823

  Gandhi, Pankaj J ^a   Murthy, Zagabathuni Venkata Panchakshari ^a  

^a SARDAR VALLABHBHAI NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-PROLIFERATIVE; COATED SYSTEMS; CONCENTRATION GRADIENTS; CORONARY ARTERIES; CORONARY VESSEL; DEPOSITION TECHNIQUE; DIP COATING; DRUG COATINGS; DRUG DELIVERY DEVICES; DRUG LOADING; DRUG RELEASE; DRUG RELEASE MECHANISM; DRUG-ELUTING STENTS; EXPOSURE-TIME; HANK'S SOLUTION; INFLAMMATORY RESPONSE; INNER LAYER; INNER LUMEN; LONG-TERM RISKS; MECHANICAL ABRASION; RELEASE CHARACTERISTICS; REVASCULARIZATION; SAMPLE SURFACE; SIROLIMUS; SPRAY METHOD; STATISTICAL TECHNIQUES; SURFACE CHARACTERISTICS; TIME INTERVAL; ULTRASONIC ATOMIZATION;

ADSORPTION; BALLOONS; BRUSHES; DRUG DELIVERY; DRUG PRODUCTS; ENGINEERING RESEARCH; MATHEMATICAL MODELS; PHOSPHOLIPIDS; STENTS;

COATINGS;

EID: 84865514485     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/ie3006676     Document Type: Article

References (102)

1. Serruys, P. W.; Ong, A. T. L.; Herwerden, L. A. J.; Sousa, E.; Jatene, A.; Bonnier, J. J. R. M.; Schönberger, J. P. M. A.; Buller, N.; Bonser, R.; Disco, C.; Backx, B.; Hugenholtz, P. G.; Firth, B. G.; Unger, F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the arterial revascularization therapies study (ARTS) randomized trial J. Am. Coll. Cardiol. 2005, 46, 575
2. Virmani, R.; Guagliumi, G.; Farb, A.; Musumeci, G.; Grieco, N.; Motta, T.; Mihalcsik Tespili, L. M.; Valsecchi, O.; Kolodgie, F. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we be cautious? Circulation 2004, 109, 701
3. Finn, A. V.; Nakazawa, G.; Joner, M.; Kolodgie, F. D.; Mont, E. K.; Gold, H. K.; Virmani, R. Vascular responses to drug eluting stents importance of delayed healing Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1500
4. Leon, M. B.; Abizaid, A.; Moses, J. W. The CYPHER Stent: A New Gold Standard in the Treatment of Coronary Artery Disease; The Cardiovascular Research Foundation: New York, 2003.
5. Kamath, K.; Barry, J.; Miller, K. The Taxus drug-eluting stent: A new paradigm in controlled drug delivery Adv. Drug. Deliv. Rev. 2006, 58, 412
6. Windecker, S.; Juni, P. The drug-eluting stent saga Circulation 2009, 119, 653
7. van der Giessen, W. J.; Lincoff, A. M.; Schwartz, R. S.; van Beusekom, H. M. M.; Serruys, P. W.; Holmes, D. R., Jr.; Ellis, S. G.; Topol, E. J. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 1996, 94, 1690
8. Oberhoff, M.; Kunert, W.; Herdeg, C.; Küttner, A; Kranzhöfer, A; Horch, B; Baumbach, A; Karsch, K. R. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter Basic Res. Cardiol. 2000, 96 (3) 275
9. Herdeg, C.; Oberhoff, M.; Baumbach, A.; Haase, K. K.; Horch, B.; Kranzhoefer, A.; Karsch, K. R. Local drug delivery with porous balloons in the rabbit: Assessment of vascular injury for an improvement of application parameters Cathet. Cardiovasc. Diagn. 1997, 41 (3) 308
10. Scheller, B.; Speck, U.; Abramjuk, C.; Bernhardt, U.; Bohm, M.; Nickenig, G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 2004, 110, 810
11. Posa, A.; Hemetsberger, R.; Petnehazy, O.; Petrasi, Z.; Testor, M.; Glogar, D.; Gyongyosi, M. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries Coron. Artery Dis. 2008, 19, 243
12. Unverdorben, M.; Vallbracht, C.; Cremers, B.; Heuer, H.; Hengstenberg, C.; Maikowski, C.; Werner, G. S.; Antoni, D.; Kleber, F. X.; Bocksch, W.; Leschke, M.; Ackermann, H.; Boxberger, M.; Speck, U.; Degenhardt, R.; Scheller, B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 2009, 119, 2986
13. Scheller, B.; Hehrlein, C.; Bocksch, W.; Rutsch, W.; Haghi, D.; Dietz, U.; Bohm, M.; Speck, U. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin. Res. Cardiol. 2008, 97, 773
14. Cremers, B.; Speck, U.; Kaufels, N.; Mahnkopf, D.; Kühler, M.; Böhm, M.; Scheller, B. Drug eluting balloon: Very short term exposure and overlapping Thromb. Haemostasis 2009, 101, 201
15. Silber, S. The Valentines trial. Presented at Cardiovascular Research Technologies, Washington, DC, 2011.
16. Scheller, B. The Invatec IN-PACT Falcon paclitaxel DEB: device description and clinical studies. Presented at Transcatheter Cardiovascular Therapeutics, Washington, DC, 2010.
17. Hehrlein, C. The Pantera Lux paclitaxel DEB-Device description and clinical studies. Presented at Transcatheter Cardiovascular Therapeutics Washington, DC, 2010.
18. Finn, A. V.; Kolodgie, F. D.; Harnek, J.; Guerrero, L. J.; Acampado, E.; Tefera, K.; Skorija, K.; Weber, D. K.; Gold, H. K.; Virmani, R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus or paclitaxel-eluting stents Circulation 2005, 112, 270
19. Wessely, R.; Blaich, B.; BelAiba, R. S.; Merl, S.; Görlach, A.; Kastrati, A.; Schömig, A. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery Thromb. Haemost. 2007, 97, 1003
20. Wang, T. H.; Wang, H. S.; Soong, Y. K. Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together Cancer 2000, 88, 2619
21. Sousa, J. E.; Costa, M. A.; Abizaid, A. C.; Rensing, B. J.; Abizaid, A. S.; Tanajura, L. F.; Kozuma, K.; Van Langenhove, G.; Sousa, A. G.; Falotico, R.; Jaeger, J.; Popma, J. J.; Serruys, P. W. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up Circulation 2001, 104, 2007
22. Roqué, M.; Reis, E. D.; Cordon-Cardo, C.; Taubman, M. B.; Fallon, J. T.; Fuster, V.; Badimon, J. J. Effect of p27 deficiency and rapamycin on intimal hyperplasia: In vivo and in vitro studies using a p27 knockout mouse model Lab. Invest. 2001, 81, 895
23. Roque, M.; Cordon-Cardo, C.; Fuster, V.; Reis, E. D.; Drobnjak, M.; Badimon, J. J. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model Atherosclerosis 2000, 153, 315
24. Gallo, R.; Padurean, A.; Jayaraman, T.; Marx, S.; Roque, M.; Adelman, S.; Chesebro, J.; Fallon, J.; Fuster, V.; Marks, A.; Badimon, J. J. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle Circulation 1999, 99, 2164
25. Marx, S. O.; Jayaraman, T.; Go, L. O.; Marks, A. R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells Circ. Res. 1995, 76, 412
26. Schwartz, S. M. Smooth muscle migration in atherosclerosis and restenosis J. Clin. Invest. 1997, 100, S87
27. Levin, A. D.; Vukmirovic, N.; Hwang, C. W.; Edelman, E. R. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 9463
28. Nasser, T. K.; Wilensky, R. L.; Mehdi, K.; March, K. L. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy Am. Heart J. 1996, 131, 892
29. Rome, J. J.; Shayani, V.; Flugelman, M. Y.; Newman, K. D.; Farb, A.; Virmani, R.; Dichek, D. A. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector Arterioscl. Thromb. 1994, 14, 148
30. Hwang, C. W.; Levin, A. D.; Jonas, M.; Li, P. H.; Edelman, E. R. Thrombosis modulates arterial drug distribution for drug-eluting stents Circulation 2005, 111, 1619
31. Gandhi, P. J.; Murthy, Z. V. P. Kinetic study of ultrasonic antisolvent crystallization of sirolimus Cryst. Res. Technol. 2010, 45, 321
32. Raval, A.; Choubey, A.; Engineer, C.; Kotadia, H.; Kothwala, D. Novel biodegradable polymeric matrix coated cardiovascular stent for controlled drug delivery Trends Biomater. Artif. Organs. 2007, 20 (2) 101
33. Acharya, G.; Park, K. Mechanisms of controlled drug release from drug-eluting stents Adv. Drug. Deliv. Rev. 2006, 58, 387
34. Basalus, M. W.; Ankone, M. J.; van Houwelingen, G. K.; de Man, F. H.; von Birgelen, C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy EuroIntervention 2009, 5, 157
35. Basalus, M. W.; van Houwelingen, K. G.; Ankone, M.; de Man, F. H.; von Birgelen, C. Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents EuroIntervention 2009, 5, 505
36. Raval, A.; Parikh, J.; Engineer, C. Mechanism and in vitro release kinetic study of Sirolimus from a biodegradable polymeric matrix coated cardiovascular stent Ind. Eng. Chem. Res. 2011, 50, 9539
37. Holvoet, S.; Chevallier, P.; Turgeon, S.; Mantovani, D. Toward high-performance coatings for biomedical devices: Study on plasma-deposited fluorocarbon films and ageing in PBS Materials 2010, 3, 1515
38. Hirlekar, R.; Patel, M.; Jain, S.; Kadam, V. Drug eluting coronary artery stents Curr. Drug Delivery 2010, 7 (5) 421
39. 2 film deposited by plasma enhanced chemical vapor deposition as a drug-combining matrix J. Mater. Chem. 2010, 20, 4792
40. X trial Circulation 2005, 111, 2617
41. 5 ceramic coating on Ti-6Al-4V with excellent bonding strength, stability and cellular bioactivity J. R. Soc., Interface 2009, 6 (31) 159
42. Nam, S. H.; Nam, H. Y.; Joo, J. R.; Baek, I. S.; Park, J. S. Curcumin-loaded PLGA nanoparticles coating onto metal stent by electrophoretic deposition techniques Bull. Korean Chem. Soc. 2007, 28, 397
43. Nukala, R. K.; Boyapally, H.; Slipper, I. J.; Mendham, A. P.; Douroumis, D. The application of electrostatic dry powder deposition technology to coat drug-eluting stents Pharm. Res. 2010, 27, 72
44. Yao, C.; Storey, D.; Webster, T. J. Nanostructured metal coatings on polymers increase osteoblast attachment Int. J. Nanomed. 2007, 2, 487
45. Okner, R.; Domb, A. J.; Mandler, D. Electrochemically deposited poly(ethylene glycol)-based sol-gel thin films on stainless steel stents New J. Chem. 2009, 33, 1596
46. Levy, Y.; Paz, A.; Yosef, R. B.; Corn, B. W.; Vaisman, B.; Shuhat, S.; Domb, A. J. Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer J. Biomed. Mater. Res., B. Appl. Biomater. 2009, 91, 855
47. Fan, Y.; Marlin, L.; Sahatjian, R. A.; Schultz, S. A. Medical device with lubricious coating. United States Patent No. 5509899, 1996.
48. Jariwala, A.; Engineer, C.; Kotadia, H.; Raval, A.; Kothwala, D. New generation sirolimus eluting PTCA angioplasty balloon catheter for restenosis therapy Trends Biomater. Artif. Organs 2008, 22 (2) 87
49. Chen, M. C.; Liang, H. F.; Chiu, Y. L.; Chang, Y.; Wei, H. J.; Sung, H. W. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus J. Controlled Release 2005, 108, 178
50. Cremers, B.; Biedermann, M.; Mahnkopf, D.; Böhm, M.; Scheller, B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model Clin. Res. Cardiol. 2009, 98 (5) 325
51. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension J. Pharm. Sci. 1961, 50, 847
52. Korsmeyer, R. W.; Gurny, R.; Doelker, E. M.; Buri, P.; Peppas, N. A. Mechanism of solute release from porous hydrophilic polymers Int. J. Pharm. 1983, 15, 25
53. Peppas, N. A. Analysis of Fickian and non-Fickian drug release from polymers Pharm. Acta Helv. 1985, 60, 110
54. Hixson, A. W.; Crowell, J. H. Dependence of reaction velocity upon surface and agitation Ind. Eng. Chem. 1931, 23, 923
55. Luderer, F.; Löbler, M.; Rohm, H. W.; Gocke, C.; Kunna, K.; Köck, K.; Kroemer, H. K.; Weitschies, W.; Schmitz, K. P.; Sternberg, K. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application J. Biomater. Appl. 2011, 25, 851
56. Panyam, J.; Labhasetwar, V. Dynamics of endocytosis and exocytosis of poly(d, l -lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharm. Res. 2003, 20, 212
57. Westedt, U.; Barbu-Tudoran, L.; Schaper, A. K.; Kalinowski, M.; Alfke, H.; Kissel, T. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localisation by confocal laser scanning microscopy and transmission electron microscopy AAPS PharmSci 2002, 4 (4) E41
58. Neugart, F.; Zappe, A.; Jelezko, F.; Tietz, C.; Boudou, J. P.; Krueger, A.; Wrachtrup, J. Dynamics of diamond nanoparticles in solution and cells Nano Lett. 2007, 7, 3588
59. Müller, R. H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future Adv. Drug Delivery 2001, 47, 3
60. ASTM Standard D 4187-82, ζ-Potential of Colloids in Water and Waste Water; American Society for Testing and Materials: West Conshohocken, PA, 1985.
61. Gandhi, P. J.; Murthy, Z. V. P.; Pati, R. K. Optimization of process parameters by Taguchi robust design method for the development of nano-crystals of sirolimus using sonication based crystallization Cryst. Res. Technol. 2012, 47, 53
62. Gupta, V. K.; Karar, P. K. Optimization of process variables for the preparation of chitosan-alginate nanoparticles Int. J. Pharm. Pharm. Sci. 2011, 3, 78
63. FDA Draft Guidance for Industry: Coronary Drug-Eluting Stents-Nonclinical and Clinical Studies; U.S. Food and Drug Administration: Washington, DC, 2008.
64. Domján, D.; Molnár, L. M.; Bognár, E.; Balázs, T. Development of polymer coatings for coronary stents Mater. Sci. Forum 2010, 659, 141
65. Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: Formulation, process, and storage considerations Adv. Drug Delivery Rev. 2006, 58, 1688
66. Avgoustakis, K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: Preparation, properties, and possible applications in drug delivery Curr. Drug Delivery 2004, 1, 321
67. Bozdag, S.; Dillen, K.; Vandervoort, J.; Ludwig, A. The effect of freeze-drying with different cryoprotectants and γ-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(d, l -lactide-glycolide) nanoparticles J. Pharm. Pharmacol. 2005, 57, 699
68. Dalwadi, G.; Benson, H. A.; Chen, Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions Pharm. Res. 2005, 22, 2152
69. Chen, W.; Allen, J. K.; Mistree, F.; Tsui, K. L. A procedure for robust design: minimizing variations cause by noise factors and control factors J. Mech. Design 1996, 118, 478
70. Ross, P. J. Taguchi Techniques for Quality Engineering, 2 nd ed.; McGraw Hill International: Singapore, 1996.
71. Kamran, A.; Guozhu, L.; Rafique, A. F.; Zeeshan, Q. ±3-Sigma based design optimization of 3D Finocyl grain. Aerosp Sci. Technol. 2012, DOI: 10.1016/j.ast.2012.02.011.
72. Evans, J. R.; Lindsay, W. M. The Management and Control of Quality, 5 th ed.; West Publishing: St. Paul, MN, 2001.
73. Raval, A.; Parikh, J.; Engineer, C. Dexamethasone eluting biodegradable polymeric matrix coated stent for intravascular drug delivery Chem. Eng. Res. Des. 2010, 88, 1479
74. Wille, J. J.; Farkas, J.; Kydonieus, A. K. Bioadhesive mechanisms: FTIR studies on hydration induced hydrocolloid/rubber phase reversal Prac. Int. Symp. Control. Rel. Bioact. Mater. 1991, 18, 113
75. Fricker, G.; Kromp, T.; Wendel, A.; Blume, A.; Zirkel, J.; Rebmann, H.; Setzer, C.; Quinkert, R. O.; Martin, F.; Muller-Goymann, C. Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 2010, 27, 1469
76. Ranga Rao, K. V.; Ben-Amor, A.; Buri, P. Studies of buccoadhesive tablet formulation of codeine phosphate S.T.P. Pharma 1989, 5, 899
77. Dittgen, M.; Oestereich, S. Development of a bioadhesive oral drug delivery system S.T.P. Pharma 1989, 5, 867
78. Kinloch, A. J. Adhesion and Adhesive Science and Technology; Chapman and Hall: London, 1987.
79. Noda, I. Contact angle studies of surface-hydrophilic elastomer films J. Adhes. Sci. Technol. 1992, 6, 467
80. Voyutski, S. S. Autoadhesion and Adhesion of High Polymers; Wiley: New York, 1963.
81. Jannari, E.; Peppas, N. A. Temperature effects on inter-diffusion and adhesion of glassy/rubbery interfaces J. Adhes. 1993, 43, 101
82. Zhang, G.; Hua, I. The impact of particulates on the aqueous sonication of bromobenzene Chemosphere 2002, 46, 59
83. Makino, K.; Mossoba, M. M.; Riesz, P. Chemical effects of ultrasound on aqueous solutions. Formation of hydroxyl radicals and hydrogen atoms J. Phys. Chem. 1983, 87, 1369
84. Makino, K.; Mossoba, M. M.; Riesz, P. Chemical effects of ultrasound on aqueous solutions. Evidence for •OH and •H by spin trapping J. Phys. Chem. 1982, 87, 3537
85. Riesz, P.; Kondo, T. Free radical formation induced by ultrasound and its biological implications Free Radical Bio. Med. 1992, 13, 247
86. Ramsden, D. K.; McKay, K. Degradation of polyacrylamide in aqueous solution induced by chemically generated hydroxyl radicals: Part I-Fenton's reagent Polym. Degrad. Stab. 1986, 14, 217
87. Guo, X. W.; Ding, W. J.; Lu, D.; Zhai, C. Q. Influence of ultrasonic power on the structure and composition of anodizing coatings formed on Mg alloys Surf. Coat. Technol. 2004, 183, 259
88. Nguyen, V. S.; Rouzel, D.; Hadji, R.; Vincent, B.; Fort, Y. Effect of ultrasonication and dispersion stability on the cluster size of alumina nanoscale particles in aqueous solutions Ultrason. Sonochem. 2011, 18, 382
89. Yu, D.; Liu, B.; Wang, B. The effect of ultrasonic waves on the nucleation of pure water and degassed water Ultrason. Sonochem. 2012, 19, 459
90. Bourne, N. K.; Field, J. E. A high speed photographic study of a cavitation damage J. Appl. Phys. 1995, 78, 4423
91. Gao, P.; Nixson, P. R.; Skoug, W. Diffusion in HPMC Gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage forms Pharm. Res. 1995, 12, 965
92. Mesnukul, A.; Phaechamud, T. Drug release through PEG-xanthan gum-lactose matrix comprising different amount of drug Thai Pharm. Health Sci. J. 2009, 4, 153
93. Gohel, M. C.; Panchal, M. K.; Jogani, V. V. Novel mathematical method for quantitative expression of deviation from the higuchi model. AAPS PharmSciTech 2000, 1, Article 31, 43.
94. Barten, A. P. Note in the unbiased estimation of the square multiple correlation coefficient Stat. Neerlandica 1962, 16, 151-163
95. Wilcox, R. R. Introduction to Robust Estimation and Hypothesis Testing; Elsevier Academic Press: Burlington, 2005.
96. Barnet, V.; Lewis, T. Outliers in Statistical Data, 3 rd ed.; John Wiley & Sons: Chichester, 1994.
97. Akaike, H. A new look at the statistical model identification IEEE Trans. Autom. Control 1974, 19, 716
98. Strand, S. E.; Zanzonico, P.; Johnson, T. K. Pharmacokinetic modeling Med. Phys. 1993, 20, 515
99. Glatting, G.; Kletting, P.; Reske, S. N.; Hohl, K.; Ring, C. Choosing the optimal fit function: Comparision of the Akaike information criterion and the F-test Med. Phys. 2007, 34, 4285
100. Cavanaugh, J. E.; Shumway, R. H. An Akaike information criterion for model selection in the presence of incomplete data J. Stat. Plan. Infer. 1998, 67, 45
101. Hermanto, M. W.; He, G.; Tjahjono, M.; Chow, P. S.; Tan, R. B. H.; Garland, M. Calibration of dielectric constant measurements to improve the detection of cloud and clear points in solution crystallization Chem. Eng. Res. Des. 2011, 89, 2613
102. Akpa, O. M.; Unuabonah, E. I. Small-sample corrected Akaike information criterion: An appropriate statistical tool for ranking of adsorption isotherm models Desalination 2011, 272, 20